Therapeutic Asset Ratings

1,537 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs Myelodysplastic Syndromes	Fred Hutchinson Cancer Center	P2/3	BB (68)
Carboplatin Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer	AbbVie	P2/3	BB (68)
Cediranib Ovarian Serous Adenocarcinoma	National Cancer Institute (NCI)	P2/3	BB (68)
CIS-DIAMMINEDICHLOROPLATINUM II BRCA1 Mutation Carrier	University Health Network, Toronto	P2/3	BB (68)
CIS-DIAMMINEDICHLOROPLATINUM II Diffuse Large B-cell Lymphoma Recurrent	Institute of Hematology & Blood Diseases Hospital, China	P2/3	BB (68)
Cladribine Myelodysplastic Syndrome	University of Florida	P2/3	BB (68)
Clofarabine Myelodysplastic Syndrome	Memorial Sloan Kettering Cancer Center	P2/3	BB (68)
Cyclophosphamide Diamond-Blackfan Anemia	Paul Szabolcs	P2/3	BB (68)
Cyclophosphamide IIM- Idiopathic Inflammatory Myopathies	The Children's Hospital of Zhejiang University School of Medicine	P2/3	BB (68)
DEXAMETHASONE Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)	The Affiliated People's Hospital of Ningbo University	P2/3	BB (68)
Docetaxel HER2 Negative Breast Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P2/3	BB (68)
Eloxatin Islet Cell Carcinoma	Alliance for Clinical Trials in Oncology	P2/3	BB (68)
Fludarabine Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2/3	BB (68)
Genotropin Growth Hormone Treatment	University of Calgary	P2/3	BB (68)
Hydroxyurea Beta-Thalassemia	National Heart, Lung, and Blood Institute (NHLBI)	P2/3	BB (68)
Inno-206 Neoplasm	The First Affiliated Hospital of Soochow University	P2/3	BB (68)
Lipitor Advanced Cancers	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2/3	BB (68)
Pembrolizumab Uveal Melanoma	BioInvent International AB	P2/3	BB (68)
Thiotepa Adult Acute Lymphoblastic Leukemia in Remission	Fifth Affiliated Hospital, Sun Yat-Sen University	P2/3	BB (68)
Tucidinostat Leukemia, Lymphoblastic	Nanfang Hospital, Southern Medical University	P2/3	BB (68)
Venetoclax Chronic Myelomonocytic Leukemia	Servier Bio-Innovation LLC	P2/3	BB (68)
(+)-VINCRISTINE Advanced Pancreatic Neuroendocrine Tumor	M.D. Anderson Cancer Center	P2/3	BB (68)
VINCRISTINE SULFATE High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements	National Cancer Institute (NCI)	P2/3	BB (68)
VINCRISTINE SULFATE Intravascular Large B-Cell Lymphoma	Northwestern University	P2/3	BB (68)
agb101 Prodromal Alzheimer's Disease	AgeneBio	P2/3	BB (67)

Showing 76 to 100 of 1,537 assets

PreviousPage 4 of 62Next